Unknown

Dataset Information

0

Bilirubin deficiency renders mice susceptible to hepatic steatosis in the absence of insulin resistance


ABSTRACT: Plasma concentrations of bilirubin, a product of heme catabolism formed by biliverdin reductase A (BVRA), inversely associate with the risk of metabolic diseases including hepatic steatosis and diabetes mellitus in humans. Bilirubin has antioxidant and anti-inflammatory activities and may also regulate insulin signaling and peroxisome proliferator-activated receptor alpha (PPARα) activity. However, a causal link between bilirubin and metabolic diseases remains to be established. Here, we used the global Bvra gene knockout (Bvra–/–) mouse as a model of deficiency in bilirubin to assess its role in metabolic diseases.

ORGANISM(S): Mus musculus (mouse)

SUBMITTER:  

PROVIDER: S-BSST1038 | biostudies-other |

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC8498001 | biostudies-literature
| S-EPMC6911300 | biostudies-literature